SINGLE CENTER, EXPLORATORY, OPEN-LABEL PROSPECTIVE STUDY USING THE MINIMALLY INVASIVE LYSINDAIR PROCEDURE (ADMINISTRATION OF THE LYSIN CF-301 DURING THE PERFORMANCE OF AN ARTHROSCOPIC DAIR) IN PATIENTS WITH CHRONIC COAGULASE-NEGATIVE STAPHYLOCOCCI KNEE PJI WITH TWO DIFFERENT CLINICAL PRESENTATIONS AND TREATMENT PARADIGMS